Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry JapanObservational Study Published on 2022-10-012022-10-05 Journal: Journal of cardiology [Category] [DOI] 10.1016/j.jjcc.2022.04.001 PMC 바로가기 [Article Type] Observational Study
Research interrupted: applying the CONSERVE 2021 Statement to a randomized trial of rehabilitation during critical illness affected by the COVID-19 pandemicRandomized Controlled Trial Published on 2022-09-022022-10-05 Journal: Trials [Category] [DOI] 10.1186/s13063-022-06640-y PMC 바로가기 [Article Type] Randomized Controlled Trial
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19COVID-19로 입원하지 않은 성인을 대상으로 한 무작위 시험에서 밤라니비맙의 항바이러스 및 임상 활성Randomized Controlled Trial Published on 2022-08-222022-09-11 Journal: Nature Communications [Category] [DOI] 10.1038/s41467-022-32551-2 PMC 바로가기 [Article Type] Randomized Controlled Trial
Attractive targeted sugar bait phase III trials in Kenya, Mali, and Zambia케냐, 말리, 잠비아에서 매력적인 표적 설탕 미끼 3상 시험Clinical Trial Published on 2022-08-092022-09-11 Journal: Trials [Category] [DOI] 10.1186/s13063-022-06555-8 PMC 바로가기 [Article Type] Clinical Trial
Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial Research Published on 2022-08-082022-10-05 Journal: Nature Medicine [Category] [DOI] 10.1038/s41591-022-01919-8 [Article Type] Research
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialCOVID-19 회복기 참가자에 대한 FINLAY-FR-1A 백신의 안전성 및 면역원성: 공개 라벨 2a상 및 이중 맹검, 무작위 배정, 위약 대조, 2b상, 심리스, 임상 시험Clinical Trial Published on 2022-08-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] [DOI] 10.1016/S2213-2600(22)00100-X PMC 바로가기 [Article Type] Clinical Trial
Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain studyCOVID-19 등재 백신 효과의 도시 모니터링, 평가 및 적용: 건강 코드 블록체인 연구Article Published on 2022-07-132022-09-11 Journal: BMJ Open [Category] [DOI] 10.1136/bmjopen-2021-057281 PMC 바로가기 [Article Type] Article
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US미국 성인의 코로나19 외래환자 치료를 위한 몰누피라비르 대 최상의 지지 요법의 비용 효율성 분석Article Published on 2022-07-012022-09-11 Journal: PharmacoEconomics [Category] [DOI] 10.1007/s40273-022-01168-0 PMC 바로가기 [Article Type] Article
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trialSARS-CoV-2 및 S-Trimer(SCB-2019) COVID-19 백신에 대한 이전 노출이 재감염 위험에 미치는 영향: 무작위 배정, 이중 맹검, 위약 대조, 2상 및 3상 시험Clinical Trial Published on 2022-07-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] [DOI] 10.1016/S1473-3099(22)00144-X PMC 바로가기 [Article Type] Clinical Trial
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study중증 COVID-19에 대한 회복기 혈장의 안전성 및 효능: 무작위, 단일 맹검, 병렬, 대조 임상 연구Randomized Controlled Trial Published on 2022-06-272022-09-11 Journal: BMC Infectious Diseases [Category] [DOI] 10.1186/s12879-022-07560-7 PMC 바로가기 [Article Type] Randomized Controlled Trial